TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01076140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04567550 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01523639 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03267940 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT02740972 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00327054 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03211650 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00460551 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01840605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03298321 — Predictive Biomarker (PRD): PITX2 mRNA
Genes: PITX2; ARP1; RGS; RIEG; RIEG1
Study NCT01294865 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT02798263 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT04945980 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04945980 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04818866 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04818866 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT04818866 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04818866 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04818866 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01568177 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03620019 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03620019 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01174238 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00051961 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04588051 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04588051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04588051 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00422630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02540187 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT01119001 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT03205163 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02721823 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00642096 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02500381 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02338349 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02620267 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT00006173 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00708175 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00985322 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01578967 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00650572 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00050726 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00911079 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT00796705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04532853 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT01890148 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study NCT04025723 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04449913 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study NCT02014155 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02014155 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03513172 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03513172 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01866865 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01330914 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01565655 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01198886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04132453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04258371 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04590274 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00582634 — Predictive Biomarker (PRD): ERCC2 mRNA
Genes: ERCC2; XPD; XPDC
Study NCT00582634 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT00720655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02544217 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04576143 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05165147 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00389168 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00389168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03243045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00493545 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00887250 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00566397 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04365582 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02657096 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00985998 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00985998 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04201756 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04201756 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04201756 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02575807 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03270436 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04597541 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00925795 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00925795 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00925795 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00925795 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00735215 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01017965 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03038165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03177863 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01674712 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01674712 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01674712 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01284062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01093612 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01093612 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03901235 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03519958 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02900469 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT04383652 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02929797 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT01275352 — Predictive Biomarker (PRD): CLCNKA mRNA
Genes: CLCNKA
Study NCT04235140 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT01814397 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02748837 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT00770237 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02718651 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02718651 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00270465 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00141323 — Surrogate Endpoint (SUR): New morphometric vertebral fractures
Study NCT00625950 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03845582 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03845582 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01098136 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT02537977 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01896752 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT00372749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04522895 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT01685736 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03689543 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01691391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01691391 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03240757 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04838015 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04841447 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00142740 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study NCT00986440 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03872232 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03872232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00312533 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00899405 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02184585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05839782 — Predictive Biomarker (PRD): FXYD1 mRNA
Genes: FXYD1; PLM
Study NCT03220087 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03698890 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00124371 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02016833 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03316781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01087112 — Predictive Biomarker (PRD): PIR mRNA
Genes: PIR
Study NCT03359590 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02195271 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT02701738 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03777332 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02319174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02402608 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05110118 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05110118 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00555555 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02400450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02414724 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT02423746 — Predictive Biomarker (PRD): DHH mRNA
Genes: DHH
Study NCT01557348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02833844 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02819765 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02749448 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03813446 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02753140 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study NCT04392505 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02150330 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study NCT02150330 — Predictive Biomarker (PRD): VCAN mRNA
Genes: VCAN; CSPG2
Study NCT02150330 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT02150330 — Predictive Biomarker (PRD): RUNX2 mRNA
Genes: RUNX2; AML3; CBFA1; OSF2; PEBP2A
Study NCT02150330 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT02150330 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT04597814 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04597814 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04080804 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04080804 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT04080804 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04080804 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT01180855 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study NCT03028766 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT04740528 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT01423877 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04111432 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04680494 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04680494 — Safety Biomarker (SAF): BDNF
Study NCT01623245 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02901184 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01213641 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT05542940 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05542940 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03637101 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04066101 — Predictive Biomarker (PRD): TAS1R1 mRNA
Genes: TAS1R1; GPR70; T1R1; TR1; GM148
Study NCT04066101 — Predictive Biomarker (PRD): TAS1R3 mRNA
Genes: TAS1R3; T1R3; TR3
Study NCT04066101 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT04066101 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT04066101 — Predictive Biomarker (PRD): CA6 mRNA
Genes: CA6
Study NCT00939068 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03506724 — Predictive Biomarker (PRD): ADRB1 mRNA
Genes: ADRB1; ADRB1R; B1AR
Study NCT00171938 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00936325 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05241509 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT02206165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05370066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00464516 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00076752 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00076752 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02796352 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02796352 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02410941 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00234494 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01612338 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00436332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00347672 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00022048 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00521950 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT03819010 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03819010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00601991 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00601991 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00049452 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03768479 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03768479 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02135861 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study NCT01269346 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00000509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01012609 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04707612 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00459498 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT02588651 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03910712 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03910712 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03910712 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03910712 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03491709 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03491709 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00383929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01139138 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04159415 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02822222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04233567 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT04109807 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02709525 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00003181 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00003181 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01158651 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT03480256 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02217189 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04042558 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04042558 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04042558 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04008355 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03573648 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00559585 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00438503 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00438503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04147325 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03691090 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03954899 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00651001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00651001 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00651001 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01026142 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01026142 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02118142 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT01261754 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01264341 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01294683 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03067155 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04269135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04212988 — Predictive Biomarker (PRD): SCO2 mRNA
Genes: SCO2
Study NCT02437734 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03069599 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03050736 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03595592 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01250418 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT00790803 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF